Single Nucleotide Polymorphisms Genotyping Market Size Outlook
Market Size
According to Straits Research, the global Single Nucleotide Polymorphisms (SNP) Genotyping Market was valued at USD 9.6 billion in 2023 and is projected to grow from USD 10.5 billion in 2024 to USD 22.6 billion by 2032. This remarkable growth is anticipated to continue at a compound annual growth rate (CAGR) of 10% during the forecast period (2024–2032).
Request a free request sample https://straitsresearch.com/report/single-nucleotide-polymorphisms-genotyping-market/request-sample
Drivers in the Single Nucleotide Polymorphisms Genotyping Market
The SNP genotyping market is driven by several key factors. First and foremost is the increasing demand for personalized medicine. As healthcare becomes more tailored to individual genetic profiles, the need for accurate and comprehensive SNP genotyping grows. Additionally, advancements in technology and the increasing affordability of genotyping techniques have made these services more accessible to a wider audience. Furthermore, the rise in genetic research and the focus on understanding genetic variations and their implications in various diseases are major contributors to market growth.
Key Developments in the Single Nucleotide Polymorphisms Genotyping Market
The SNP genotyping market has witnessed several significant developments. Companies are continually investing in research and development to improve the accuracy and efficiency of genotyping techniques. New technologies and platforms are being introduced, offering faster and more reliable results. Collaborations and partnerships between key players in the industry are also driving innovation and expanding the reach of SNP genotyping services. These developments are expected to enhance the market's growth prospects in the coming years.
Top Key Players
The SNP genotyping market is highly competitive, with several key players dominating the industry. These include:
Agilent Technologies Inc.
Eurofins Genomics (Eurofins Scientific SE)
Illumina Inc.
Integrated DNA Technologies, Inc. (Danaher Corporation)
LGC Limited
PREMIER Biosoft
Promega Corporation
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc.
This Report is available for purchase on @ https://straitsresearch.com/buy-now/single-nucleotide-polymorphisms-genotyping-market
Segmentation Analysis of the Single Nucleotide Polymorphisms Genotyping Market
The SNP genotyping market is segmented based on technology and application.
By Technology:
TaqMan SNP Genotyping
Massarray SNP Genotyping
SNP GeneChip Arrays
By Application:
Animal Genetics
Plant Improvement
Diagnostic Research
Pharmaceuticals and Pharmacogenomics
Agricultural Biotechnology
Company Details
Straits Research is a top provider of business intelligence, specializing in research, analytics, and advisory services. With a focus on delivering in-depth insights through comprehensive reports, Straits Research helps organizations make informed decisions and stay ahead in their respective markets.
Contact Us:
Email: [email protected]
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
